Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation [5]

Clinical Research in Cardiology

Volumn 97, Issue 1, 2008, Pages 49-52

  Herdeg, Christian ^a   Göhring Frischholz, Katrin ^a   Helber, Uwe ^a   Geisler, Tobias ^a   May, Andreas ^a   Haase, Karl K ^a   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DOXEPIN; FLUINDOSTATIN; PACLITAXEL;

ADULT; ANAMNESIS; ANGINA PECTORIS; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ENDOGENOUS DEPRESSION; HEART CATHETER; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITAL ADMISSION; HUMAN; HYPERLIPOPROTEINEMIA; IMPLANTATION; LETTER; RIGHT CORONARY ARTERY; TREATMENT OUTCOME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CATHETERIZATION; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL;

EID: 38149114192     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0604-6     Document Type: Letter

References (10)

1. Shuchman M (2007) Debating the risks of drug-eluting stents. N Engl J Med 356(4):325-328
2. Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker T, Senges J; for the German Cypher Stent Registry (2007) The Sirolimuseluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol 96(8):548-556
3. Khattab AA, Hamm CW, Senges J, Toelg R, Geist V, Bonzel T, Kelm M, Levenson B, Nienaber CA, Sabin G, Tebbe U, Schneider S, Richardt G; German Cypher Stent Registry (2007) Incidence and predictors of target vessel revascularization after sirolimuseluting stent treatment for proximal left anterior descending artery stenoses among 2274 patients fromthe prospectivemulticenter German Cypher Stent Registry. Clin Res Cardiol 96(5):279-284
4. Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J, Petersson I, Magounakis T, Lagerqvist B (2007) Is late stent thrombosis in drug-eluting stents a real clinical issue? A singlecenter experience and review of the literature. Clin Res Cardiol 96(2):86-93
5. Dommke C, Haase KK, Suselbeck T, Streitner I, Haghi D, Metz J, Borggrefe M, Herdeg C (2007) Local paclitaxel delivery after coronary stenting in an experimental animal model. Thromb Haemost 98(3):674-680
6. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Axel DI, Schroder S, Heinle H, Karsch KR (2000) Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 35(7):1969-1976
7. Wohrle J, Nusser T, Kestler HA, Kochs M, Hombach V (2007) Comparison of the slow-release polymerbased paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol 96(2):70-76
8. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR (1997) Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96(2):636-645
9. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Kuttner A, Schroder S, Haase KK, Karsch KR (1999) Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types. Basic Res Cardiol 94(6):454-463
10. Scheller B, Hehrlein C, Bocksch WI, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U (2006) Treatment of coronary in-stent restenosis with a paclitaxel- coated balloon catheter. N Engl J Med 355(20):2113-2124